Therapeutic Area Market Research Reports & Industry Analysis
Therapeutic areas include Cardiology/Vascular Diseases, Dental and Oral Health, Dermatology, Devices, Endocrinology, Family Medicine, Gastroenterology, Genetic Disease, Healthy Volunteers, Hematology, Hepatology, Immunology, Infections and Infectious Diseases, Internal Medicine, Musculoskeletal, Nephrology, Neurology, Nutrition and Weight Loss, Obstetrics/Gynecology, Oncology, Ophthalmology, Orthopedics/Orthopedic Surgery, Otolaryngology, Pediatrics/Neonatology, Pharmacology/Toxicology, Podiatry, Psychiatry/Psychology, Pulmonary/Respiratory Diseases, Rheumatology, Sleep, Trauma, Urology, and Vaccines.
Reports in these categories will contain statistics of prevalence and growth concerning therapeutic area diseases for which there are product reviews, market size, and share for products that are used in pharmaceutical treatment or equipment that used in surgical treatment of the therapeutic area.
Therapeutic Area Industry Research & Market Reports
-
Veterinary Oncology
... CAGR of 10.9% over the analysis period 2024-2030. Chemotherapy, one of the segments analyzed in the report, is expected to record a 12.0% CAGR and reach US$246.0 Million by the end of the analysis period. ... Read More
-
Anxiolytics
... 4.6% over the analysis period 2024-2030. The U.S. Market is Estimated at US$259.8 Million While China is Forecast to Grow at 7.1% CAGR The Anxiolytics market in the U.S. is estimated at US$259.8 Million in ... Read More
-
Breastfeeding Accessories
... CAGR of 6.6% over the analysis period 2024-2030. Breastmilk Storage & Feeding, one of the segments analyzed in the report, is expected to record a 6.0% CAGR and reach US$974.4 Million by the end of ... Read More
-
Pediatric Epilepsy Therapeutics
... at a CAGR of 3.3% over the analysis period 2024-2030. Third Generation, one of the segments analyzed in the report, is expected to record a 4.0% CAGR and reach US$7.0 Billion by the end of ... Read More
-
Energy-based Therapeutics
... CAGR of 3.6% over the analysis period 2024-2030. Laser-based Technology, one of the segments analyzed in the report, is expected to record a 3.3% CAGR and reach US$3.6 Billion by the end of the analysis ... Read More
-
Urothelial Cancer Drugs
... at a CAGR of 20.7% over the analysis period 2024-2030. Immunotherapy, one of the segments analyzed in the report, is expected to record a 20.3% CAGR and reach US$13.3 Billion by the end of the ... Read More
-
Urology Surgical Instruments
... at a CAGR of 7.7% over the analysis period 2024-2030. Consumables & Accessories, one of the segments analyzed in the report, is expected to record a 8.2% CAGR and reach US$13.5 Billion by the end ... Read More
-
Veterinary Orthopedics
... CAGR of 8.4% over the analysis period 2024-2030. Implants, one of the segments analyzed in the report, is expected to record a 9.0% CAGR and reach US$768.3 Million by the end of the analysis period. ... Read More
-
Breast Reconstruction
... CAGR of 5.5% over the analysis period 2024-2030. Breast Implants, one of the segments analyzed in the report, is expected to record a 7.0% CAGR and reach US$629.5 Million by the end of the analysis ... Read More
-
Liver Cancer Drugs
... at a CAGR of 18.4% over the analysis period 2024-2030. Targeted Drug Therapy, one of the segments analyzed in the report, is expected to record a 18.4% CAGR and reach US$5.1 Billion by the end ... Read More
-
Bone and Joint Health Supplements
... Billion by 2030, growing at a CAGR of 5.8% over the analysis period 2024-2030. Joint Supplements, one of the segments analyzed in the report, is expected to record a 6.3% CAGR and reach US$14.4 Billion ... Read More
-
Pediatric Imaging
... CAGR of 7.1% over the analysis period 2024-2030. Magnetic Resonance Imaging, one of the segments analyzed in the report, is expected to record a 7.5% CAGR and reach US$5.2 Billion by the end of the ... Read More
-
Contract Research Organization Services (CROs)
... Billion by 2030, growing at a CAGR of 10.6% over the analysis period 2024-2030. Clinical Research, one of the segments analyzed in the report, is expected to record a 11.4% CAGR and reach US$76.7 Billion ... Read More
-
Cosmetic Dentistry
... CAGR of 6.3% over the analysis period 2024-2030. Dental Systems & Equipment, one of the segments analyzed in the report, is expected to record a 7.1% CAGR and reach US$14.2 Billion by the end of ... Read More
-
Congestive Heart Failure (CHF) Treatment Devices
... reach US$37.9 Billion by 2030, growing at a CAGR of 7.1% over the analysis period 2024-2030. Implantable Cardioverter Defibrillators, one of the segments analyzed in the report, is expected to record a 7.8% CAGR and ... Read More
-
Hyaluronic Acid-based Dermal Fillers
... 2030, growing at a CAGR of 7.0% over the analysis period 2024-2030. Single Phase, one of the segments analyzed in the report, is expected to record a 7.3% CAGR and reach US$4.6 Billion by the ... Read More
-
Hypertrophic and Keloid Scar Treatment
... Billion by 2030, growing at a CAGR of 9.7% over the analysis period 2024-2030. Topical, one of the segments analyzed in the report, is expected to record a 9.7% CAGR and reach US$7.3 Billion by ... Read More
-
Orthotics (UK) - Industry Report
... attractive acquisition opportunities • Analyse industry trends • Benchmark their own financial performance Using an exclusive methodology, a quick glance of this Orthotics (UK) report will tell you the companies that have a declining financial ... Read More
-
Chiropody & Podiatry Supplies (UK) - Industry Report
... failure • Seek out the most attractive acquisition opportunities • Analyse industry trends • Benchmark their own financial performance Using an exclusive methodology, a quick glance of this Chiropody & Podiatry Supplies (UK) report will ... Read More
-
Fertility Clinics (UK) - Industry Report
... the most attractive acquisition opportunities • Analyse industry trends • Benchmark their own financial performance Using an exclusive methodology, a quick glance of this Fertility Clinics (UK) report will tell you the companies that have ... Read More
-
Manufacturing Opticians (UK) - Industry Report
... the most attractive acquisition opportunities • Analyse industry trends • Benchmark their own financial performance Using an exclusive methodology, a quick glance of this Manufacturing Opticians (UK) report will tell you the companies that have ... Read More
-
Prostate Cancer Treatment Market Report by Drug Type (Chemotherapy, Biological Therapy, Hormone Therapy, and Others), Distribution Channel (Hospitals Pharmacies, Drug Stores and Retail Pharmacies, Online Pharmacies), and Region 2025-2033
... 2025-2033. The increasing prevalence of the disease, advancements in personalized medicine, the emergence of new therapies, higher healthcare spending, and growing public awareness about prostate health and available treatment options are strengthening the market growth. ... Read More
-
IVF Devices and Consumables Market Report by Product (Instruments, Accessories and Disposables, Reagents and Media), Technology (Fresh Embryo IVF, Frozen Embryo IVF, Donor Egg IVF), End User (Fertility Clinics, Hospitals, Surgical Centers, Clinical Research Institutes), and Region 2025-2033
... during 2025-2033. In vitro fertilization (IVF) is an assisted reproductive technology (ART) that helps with fertility, prevents genetic problems, and assists in the conception of a child. It comprises several medicines and surgical procedures for ... Read More
-
Biomarkers Market Report by Product (Consumables, Services, Software), Type (Efficacy Biomarkers, Safety Biomarkers, Validation Biomarkers), Disease (Cancer, Cardiovascular Disorders, Neurological Disorders, Immunological Disorders, Renal Disorders, and Others), Application (Diagnostics, Drug Discovery and Development, Personalized Medicine, and Others), End User (Pharmaceutical and Biotechnology Companies, Diagnostic and Research Laboratories, Hospitals and Specialty Clinics, and Others), and Region 2025-2033
... rising prevalence of chronic diseases, ongoing developments in biotechnology and genomics, the shift toward personalized medicine, continuous advancements in analytical technologies, and increasing awareness among both healthcare professionals and patients about the benefits of biomarkers ... Read More
-
Rosacea Treatment Market Report by Type (Erythematotelangiectatic Rosacea, Papulopustular Rosacea, Ocular Rosacea, Phymatous Rosacea), Drug Class (Antibiotics, Alpha Agonists, Retinoids, Corticosteroids, Immunosuppressants, Antihypertensive Agents, and Others), Route of Administration (Topical, Oral), Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy, and Others), End User (Hospitals, Homecare, Specialty Clinics, and Others), and Region 2025-2033
... The rising demand for oral treatments and the expanding pharmaceutical industry are primarily driving the market. Rosacea treatment refers to preventive measures adopted to cure a chronic skin disease that enlarges blood vessels and causes ... Read More
Research Assistance
